Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRS + Intraperitoneal Chemotherapy vs Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
NCT01524094Phase 3Completed
- Sponsor
- Uppsala University
- Start
- Jun 2003
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and levoleucovorin in colorectal peritoneal carcinomatosis (CRC-PC) (2 arms), sponsored by Uppsala University. Primary endpoint: Overall Survival at 8 years. Started Jun 2003; status: completed.
02
Drugs
fluorouracillevoleucovorin
03
Conditions
colorectal peritoneal carcinomatosis (CRC-PC)
Beyond the preview
Go deeper on NCT01524094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524094.